世界の非ステロイド性抗炎症薬（NSAID）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4185 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、非ステロイド性抗炎症薬（NSAID）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・非ステロイド性抗炎症薬（NSAID）の市場動向 ・企業の競争状況、市場シェア ・非ステロイド性抗炎症薬（NSAID）の種類別市場規模（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他） ・非ステロイド性抗炎症薬（NSAID）の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局） ・非ステロイド性抗炎症薬（NSAID）の北米市場規模2016-2027（アメリカ、カナダ） ・非ステロイド性抗炎症薬（NSAID）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・非ステロイド性抗炎症薬（NSAID）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・非ステロイド性抗炎症薬（NSAID）の中南米市場規模2016-2027（メキシコ、ブラジル） ・非ステロイド性抗炎症薬（NSAID）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Novartis、Pfizer、Boehringer Ingelheim、Teva Pharmaceutical、Hospira、Lonza Group、Mylan、Aurobindo Pharma、Dr. Reddy's Laboratories、Actavis、Wuxi Apptec、Zhejiang NHU） ・結論

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.

Market Analysis and Insights: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market.

Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Scope and Market Size
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy’s Laboratories
Teva Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Paracetamol
1.2.3 Ibuprofen
1.2.4 Aspirin
1.2.5 Naproxen
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2016-2027)
2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
2.2.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Share by Regions (2016-2021)
2.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027)
2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Dynamic
2.3.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
2.3.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue
3.1.1 Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2016-2021)
3.1.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2016-2021)
3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
3.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020
3.5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.6 Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.7 Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2016-2021)
4.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027)

5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2016-2021)
5.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
6.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
6.2.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
6.2.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
6.2.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
6.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
6.3.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
6.3.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
6.3.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
6.4 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
6.4.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
6.4.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
7.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
7.2.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
7.2.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
7.2.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
7.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
7.3.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
7.3.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
7.3.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
7.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.4.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
7.4.2 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
8.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
8.2.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
8.3.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
8.4.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
9.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
9.2.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
9.2.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
9.2.3 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
9.3 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
9.3.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
9.3.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
9.3.3 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
9.4 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
9.4.1 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
9.4.2 Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2016-2027)
10.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
10.2.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
10.3.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.4.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
11.5 Hospira
11.5.1 Hospira Company Details
11.5.2 Hospira Business Overview
11.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.5.5 Hospira Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Details
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.6.5 Lonza Group Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Company Details
11.8.2 Aurobindo Pharma Business Overview
11.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.8.5 Aurobindo Pharma Recent Development
11.9 Dr. Reddy’s Laboratories
11.9.1 Dr. Reddy’s Laboratories Company Details
11.9.2 Dr. Reddy’s Laboratories Business Overview
11.9.3 Dr. Reddy’s Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 Dr. Reddy’s Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.9.5 Dr. Reddy’s Laboratories Recent Development
11.10 Actavis
11.10.1 Actavis Company Details
11.10.2 Actavis Business Overview
11.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.10.5 Actavis Recent Development
11.11 Wuxi Apptec
11.11.1 Wuxi Apptec Company Details
11.11.2 Wuxi Apptec Business Overview
11.11.3 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.11.5 Wuxi Apptec Recent Development
11.12 Zhejiang NHU
11.12.1 Zhejiang NHU Company Details
11.12.2 Zhejiang NHU Business Overview
11.12.3 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
11.12.5 Zhejiang NHU Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Paracetamol
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Aspirin
Table 5. Key Players of Naproxen
Table 6. Key Players of Others
Table 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2016-2021)
Table 11. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027)
Table 13. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2016-2021)
Table 19. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020)
Table 20. Ranking of Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 24. Date of Enter into Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021)
Table 28. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2016-2021)
Table 32. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 67. Novartis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 72. Pfizer Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 77. Boehringer Ingelheim Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. Teva Pharmaceutical Company Details
Table 80. Teva Pharmaceutical Business Overview
Table 81. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 82. Teva Pharmaceutical Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 83. Teva Pharmaceutical Recent Development
Table 84. Hospira Company Details
Table 85. Hospira Business Overview
Table 86. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 87. Hospira Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 88. Hospira Recent Development
Table 89. Lonza Group Company Details
Table 90. Lonza Group Business Overview
Table 91. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 92. Lonza Group Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 93. Lonza Group Recent Development
Table 94. Mylan Company Details
Table 95. Mylan Business Overview
Table 96. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 97. Mylan Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 98. Mylan Recent Development
Table 99. Aurobindo Pharma Company Details
Table 100. Aurobindo Pharma Business Overview
Table 101. Aurobindo Pharma Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 102. Aurobindo Pharma Recent Development
Table 103. Dr. Reddy's Laboratories Company Details
Table 104. Dr. Reddy's Laboratories Business Overview
Table 105. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 106. Dr. Reddy's Laboratories Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 107. Dr. Reddy's Laboratories Recent Development
Table 108. Actavis Company Details
Table 109. Actavis Business Overview
Table 110. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 111. Actavis Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 112. Actavis Recent Development
Table 113. Wuxi Apptec Company Details
Table 114. Wuxi Apptec Business Overview
Table 115. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 116. Wuxi Apptec Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 117. Wuxi Apptec Recent Development
Table 118. Zhejiang NHU Company Details
Table 119. Zhejiang NHU Business Overview
Table 120. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 121. Zhejiang NHU Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021) & (US$ Million)
Table 122. Zhejiang NHU Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2020 VS 2027
Figure 2. Paracetamol Features
Figure 3. Ibuprofen Features
Figure 4. Aspirin Features
Figure 5. Naproxen Features
Figure 6. Others Features
Figure 7. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions: 2020 VS 2027
Figure 15. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2022-2027)
Figure 16. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2020
Figure 17. Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2020
Figure 19. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2016-2021)
Figure 20. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2022-2027)
Figure 21. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 23. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 24. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 25. United States Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 29. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 30. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 31. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2016-2027)
Figure 41. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 49. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 50. Latin America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 51. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2016-2027)
Figure 57. Turkey Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 63. Teva Pharmaceutical Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 64. Hospira Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 65. Lonza Group Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 67. Aurobindo Pharma Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 68. Dr. Reddy's Laboratories Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 69. Actavis Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 70. Wuxi Apptec Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 71. Zhejiang NHU Revenue Growth Rate in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---